QQ客服 官方微博 反馈留言

	Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy
	Lin, Ying-Li[1]; Deng, Qiu-Kui[2]; Wang, Yu-Hao[3]; Fu, Xing-Li[4]; Ma, Jian-Guo[5]; Li, Wen-Ping[6]
刊名	MEDICAL SCIENCE MONITOR
	2015
卷号	21页码:3955-3960
关键词	Biological Markers DNA Methylation Prostatic Neoplasms
ISSN号	1643-3750
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000367375400001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5389778
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Dept Urol, Xuzhou Canc Hosp, Affiliated Xuzhou Hosp, Xuzhou, Jiangsu, Peoples R China. 2.[2]Shandong Univ, Dept Orthopaed, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.,Xinyi Peoples Hosp, Dept Orthopaed, Xuzhou, Jiangsu, Peoples R China. 3.[3]Nanjing Med Univ, Dept Clin Med, Nanjing, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Hlth Sci Ctr, Zhenjiang, Jiangsu, Peoples R China. 5.[5]Hebei Med Univ, Dept Urol, Hosp 3, Shijiazhuang, Hebei, Peoples R China. 6.[6]Hebei Med Univ, Dept Urol, Hosp 3, Shijiazhuang, Hebei, Peoples R China.
推荐引用方式 GB/T 7714	Lin, Ying-Li[1],Deng, Qiu-Kui[2],Wang, Yu-Hao[3],et al. Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy[J]. MEDICAL SCIENCE MONITOR,2015,21:3955-3960.
APA	Lin, Ying-Li[1],Deng, Qiu-Kui[2],Wang, Yu-Hao[3],Fu, Xing-Li[4],Ma, Jian-Guo[5],&Li, Wen-Ping[6].(2015).Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.MEDICAL SCIENCE MONITOR,21,3955-3960.
MLA	Lin, Ying-Li[1],et al."Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy".MEDICAL SCIENCE MONITOR 21(2015):3955-3960.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。